Generic pharmaceuticals make up nine out of every 10 prescriptions in the United States and in 2025 drugs for COPD, hypertension, high cholesterol, cancer, and many other disease conditions have expiring patents, so can be produced as generics. These drugs are as effective and work the same as the name brands, but typically cost consumers significantly less. On this episode, we discuss how they're formulated to be effective, how they're scaled from laboratory to manufacturing, and why they're so important in improving access and affordability.